NFKB1 and Parkinson disease: In the MPTP-injected mouse model of PD, pioglitazone administration attenuates dopaminergic neuron death by blocking the NF-κB pathway and inhibiting iNOS (Breidert et al., 2002; Dehmer et al., 2004; Quinn et al., 2008).